Young people living with a chronic illness like type 1 diabetes (T1D) often experience anxiety which – if not treated – can quickly spiral downwards into depression. However, the link between diabetes and depression remains poorly understood and under-researched. Depression is often viewed as a natural outcome of “diabetes distress” – the emotional burden of living with the disease.
JDRF youth ambassador sets out to change the future of type 1 diabetes
Meet Noah Silvaggio, an ambitious 16-year-old JDRF youth ambassador who was voted one of Manitoba’s Top 40 Young People to Watch in 2018 in the category of community activism and social affairs.
Implant of differentiated pluripotent stem cells to treat diabetes
Dr. Timothy Kieffer, a JDRF-funded investigator and professor in the Department of Cellular and Physiological Sciences and the Department of Surgery at the University of British Columbia, has been awarded a new two-year grant to continue his research involving insulin-producing cells as a potential cure for type 1 diabetes (T1D). Read on to learn more about his current research study.
Clinical trials of islet and stem cell therapies for type 1 diabetes
Clinical islet transplantation is viewed as a viable treatment that has the potential to eliminate a life-long dependence on insulin in individuals with type 1 diabetes (T1D). Dr. Shapiro breaks down the three areas his research study will focus on.
Regulatory T cells (Tregs) and their function in T1D
Dr. Anne Maria Pesenacker, a JDRF-funded investigator at the University of British Columbia and now at UCL’s Institute of Immunity and Transplantation, is examining how regulatory T cells (Tregs) function in health and how best to monitor their fitness.
First European clinical trial in human stem cell therapy for type 1 diabetes is underway
The development of encapsulation technologies to treat insulin-dependent diabetes has been at the forefront of type 1 diabetes (T1D) research in North America for many years. This is because new methods of cell delivery may offer a functional cure for people with T1D at high risk for life-threating complications.
How to raise money for Walk using social media
It goes without saying that social media has become the way we share snippets of our lives. Not only has it revolutionized how we get a glimpse into those of our friends and family, but it has radically changed how we learn about the world around us, how we engage with government and how we unite to make our planet a better place to live.
Advocate Profile: Memorial University of Newfoundland medical students
Guest blog post by Nguyet (Na) Nguyen and Sarah Strong
The Provincial Day of Action is a yearly event where medical students identify a gap in the healthcare system and approach our provincial government with an “ask” to help fix that gap. This year, as students in the Faculty of Medicine at Memorial University of Newfoundland, we asked the provincial government to remove the age restrictions in place for financial coverage of insulin pumps for people living with type 1 diabetes (T1D) in Newfoundland and Labrador.
The 2019 federal budget and you
While the 2019 Canadian budget was eagerly anticipated by all Canadians, there were items that directly impacted members of the type 1 diabetes (T1D) community. So what does the 2019 federal budget mean for you?
Advocate Profile: Ashlynn O’Hara and not backing down from the #AccessforAll fight
Ashlynn O’Hara is 10 years old, lives with type 1 diabetes (T1D), and is taking her fight for affordable continuous glucose monitors (CGM) to the big leagues.
The 2019 Ontario Budget: How to turn disappointment into action
The results of the Ontario budget mean that your voice is now more important than ever. You can immediately support this initiative by writing, calling or meeting with your provincial or territorial representative by simply clicking here.
The impact of your story: How #AccessforAll is more successful when T1D stories are shared
Having someone with the lived experience of diabetes relate their struggles with maintaining good blood glucose to political representatives and get across just how life-changing, in some cases life-saving, CGM and FGM devices can be, changes the whole conversation.